Founding Team
GenomeDx was founded by physicians, scientists and life sciences executives from the University of Southern California in Los Angeles, the University of British Columbia and GenomeBC in Vancouver. The Company was spun out of the ‘realized-gain’ from over $20M in grant funding over the past decade by company founders and operates out of it’s Vancouver-based headquarters and Los Angeles-based CLIA-certified laboratory. The scientific team led by Prof. Timothy J. Triche is recognized for their pioneering work in DNA microarray and other genome-wide technologies for clinical applications in cancer diagnostics. Founding management and advisors have intimate knowledge of the state-of-the art in genomics and developing applications for the use of genomic technology in cancer medicine.
Bruce Schmidt, BSc Chief Executive OfficerBruce Schmidt is the Chief Executive Officer and interim Chief Financial Officer. Mr. Schmidt is an experienced life sciences entrepreneur and executive with significant prior interaction in technology start-up's and publicly-traded life science companies. Mr. Schmidt was a founding director of Genome British Columbia, a not-for-profit life sciences research institute and served in various capacities helping to invest over $300 million to build the existing genomics technology and research capabilities for the province of British Columbia. Mr. Schmidt has also served as a director for a number of high-tech and biotech companies in Canada and as Chairman of both the Life Sciences and Nanotechnology industry organizations in British Columbia. Bruce is an accomplished entrepreneur with the vision of transforming the healthcare industry into a more sustainable form through integration of genomic technology solutions.
Timothy Triche, MD PhD Chief Medical OfficerDr. Triche was the director of Specialized Diagnostics and Section Chief, Laboratory of Pathology at the National Cancer Institute for 15 years before becoming Pathologist-in-Chief at Children's Hospital of Los Angeles and Vice-Chair, Department of Pathology, Keck School of Medicine, University of Southern California. He is a founding member of the Association for Molecular Pathology and has previously served as a senior executive, in a number of medical companies, including Chairman and CEO of Oncormed. Dr. Triche's research group is working closely with several large international research consortiums, including the Children's Oncology Group on basic and applied research in cancer genomics and is the founder of the Center for Personalized Medicine at Children's Hospital Los Angeles. Tim is a pioneer in the molecular diagnostics field for over 30 years, a world-renowned expert pathologist in cancer with over 200 peer-reviewed publications and a visionary for advancing genomic technology into the practice of medicine.
Elai Davicioni, PhD Chief Scientific OfficerDr. Davicioni was trained as a pathobiologist in Dr. Triche's research group and worked in close collaboration with the Children's Oncology Group on genomic analysis of pediatric cancer patients. The focus of this work has been to create enabling genomics technologies for healthcare professionals and developing computational algorithms and approaches for the diagnosis and prognosis of children with cancer using microarrays. Elai is a developer of GenomeDx's platform technology and the author of several patents and peer-reviewed publications for the Company's cancer research and molecular diagnostic programs. Previously, Elai worked at Compugen, a leading Israeli computational biology company and retains close ties to academic medicine through an appointment at the Department of Pathology at the University of British Columbia.
Jonathan Buckley, MD PhD Chief Technology OfficerDr. Buckley was trained as a medical doctor before becoming involved in molecular epidemiology research in Australia and the UK. Currently, he is a Professor of Research at the Department of Preventative Medicine at the USC Keck School of Medicine, the Norris Comprehensive Cancer Center and Director of Bioinformatics at the USC Epigenome Center. Dr. Buckley's areas of expertise include genomic analysis, biostatistics, clinical trial analysis and software development. Jonathan has developed many of the bioinformatics and computational algorithms used by GenomeDx to interrogate large amounts of genomics data. He and his team have developed a unique software package that is objectively the best in the world at integrating the many different layers of information encoded in the human genome.
Zaid Haddad, BSc Genomics Analyst and ProgrammerZaid Haddad has a joint degree in computing science and molecular biology and biochemistry from Simon Fraser University. Zaid Haddad's position as a genomics analyst and programmer includes developing biocomputing algorithms and new methods and implementations for the analysis of whole-genome microarray data.
Please contact our CEO (bruce[at]genomedx.com) to inquire further about business partnerships and collaborative research opportunties.